Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations.
Dionysios Mitropoulos, Walter Artibani, Markus Graefen...
https://pubmed.ncbi.nlm.nih.gov/22074761/Actively Recruiting
Led by Rigshospitalet, Denmark · Updated on 2026-08-12
420
Participants Needed
1
Research Sites
13 weeks
Total Duration
This research aims to evaluate the effect of adding antifungal medicine to standard antibiotic treatment during cystectomy, a surgery to remove the bladder and create a urinary diversion, typically an ileal conduit. This major cancer surgery exposes the abdominal cavity to bacteria and fungi, which may cause serious postoperative complications like paralytic ileus and infections. The study investigates whether perioperative antifungal prophylaxis can reduce such complications after cystectomy. Participants will receive either a single intravenous dose of 400 mg Fluconazole in saline or a placebo of intravenous saline solution, both given during surgery. This is a randomized, double-blinded, placebo-controlled trial comparing antifungal prophylaxis plus standard antibiotics versus antibiotics alone. The primary treatment occurs during the perioperative period, with follow-up assessments extending up to 90 days after surgery. During the study, participants will be monitored for postoperative complications, days alive and out of hospital, gastrointestinal function recovery, need for nasogastric tube placement, length of hospital stay, readmission rates, and quality of life before surgery and 90 days afterward. Safety and outcomes will be carefully assessed throughout this period to determine the impact of adding antifungal prophylaxis to standard care for cystectomy patients.
CONDITIONS
Introduction of Mycotic Prophylaxis At Cystectomy Trial.
M
Mie Ynddal, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Rigshospitalet, Denmark
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Perioperative period
Participants receive a single intravenous dose of either Fluconazole or placebo saline solution during cystectomy surgery.
Duration - 90 days
Participants are monitored for 90 days after surgery to assess complications, recovery of gastrointestinal function, hospital stay, readmissions, and quality of life.
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Dionysios Mitropoulos, Walter Artibani, Markus Graefen...
https://pubmed.ncbi.nlm.nih.gov/22074761/Mie Skjøttgaard Ynddal, Hein Vincent Stroomberg, Maja Vejlgaard...
https://pubmed.ncbi.nlm.nih.gov/42380957/Deborah J Lightner, Kevin Wymer, Joyce Sanchez...
https://pubmed.ncbi.nlm.nih.gov/31441676/Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/Heidi Cecilie Villmones, Adrian Halland, Tore Stenstad...
https://pubmed.ncbi.nlm.nih.gov/32835795/Sophia L Maibom, Martin A Røder, Eske K Aasvang...
https://pubmed.ncbi.nlm.nih.gov/34657367/Dionysios Mitropoulos, Walter Artibani, Chandra Shekhar Biyani...
https://pubmed.ncbi.nlm.nih.gov/28753862/D Osoba, G Rodrigues, J Myles...
https://pubmed.ncbi.nlm.nih.gov/9440735/Sophia L Maibom, Martin A Røder, Alicia M Poulsen...
https://pubmed.ncbi.nlm.nih.gov/34337519/Megan Prunty, Stephen Rhodes, Marco-Jose Rivero...
https://pubmed.ncbi.nlm.nih.gov/36383758/Rigshospitalet, Denmark
Lead Sponsor